<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Pediatr</journal-id><journal-id journal-id-type="iso-abbrev">BMC Pediatr</journal-id><journal-title-group><journal-title>BMC Pediatrics</journal-title></journal-title-group><issn pub-type="epub">1471-2431</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28356142</article-id><article-id pub-id-type="pmc">5372327</article-id><article-id pub-id-type="publisher-id">845</article-id><article-id pub-id-type="doi">10.1186/s12887-017-0845-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title>Towards evidence-based vitamin D supplementation in infants: vitamin D intervention in infants (VIDI) — study design and methods of a randomised controlled double-blinded intervention study</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6254-3180</contrib-id><name><surname>Helve</surname><given-names>Otto</given-names></name><address><phone>+358 50 58 24 426</phone><email>otto.helve@helsinki.fi</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Viljakainen</surname><given-names>Heli</given-names></name><address><email>heli.viljakainen@helsinki.fi</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Holmlund-Suila</surname><given-names>Elisa</given-names></name><address><email>elisa.holmlund@helsinki.fi</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rosendahl</surname><given-names>Jenni</given-names></name><address><email>jenni.rosendahl@hus.fi</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Hauta-alus</surname><given-names>Helena</given-names></name><address><email>helena.hauta-alus@helsinki.fi</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Enlund-Cerullo</surname><given-names>Maria</given-names></name><address><email>maria.enlund-cerullo@hus.fi</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Valkama</surname><given-names>Saara</given-names></name><address><email>saara.valkama@hus.fi</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Heinonen</surname><given-names>Kati</given-names></name><address><email>kati.heinonen@helsinki.fi</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Räikkönen</surname><given-names>Katri</given-names></name><address><email>katri.raikkonen@helsinki.fi</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Hytinantti</surname><given-names>Timo</given-names></name><address><email>timo.hytinantti@hus.fi</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Mäkitie</surname><given-names>Outi</given-names></name><address><email>outi.makitie@helsinki.fi</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Andersson</surname><given-names>Sture</given-names></name><address><email>sture.andersson@hus.fi</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0410 2071</institution-id><institution-id institution-id-type="GRID">grid.7737.4</institution-id><institution>Children’s Hospital, Pediatric Research Center, </institution><institution>University of Helsinki and Helsinki University Hospital, </institution></institution-wrap>P.O. Box 281, 00029 HUS Helsinki, Finland </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0409 6302</institution-id><institution-id institution-id-type="GRID">grid.428673.c</institution-id><institution></institution><institution>Folkhälsan Research Center, </institution></institution-wrap>Helsinki, Finland </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0410 2071</institution-id><institution-id institution-id-type="GRID">grid.7737.4</institution-id><institution>Institute of Behavioral Sciences, </institution><institution>University of Helsinki, </institution></institution-wrap>Helsinki, Finland </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9241 5705</institution-id><institution-id institution-id-type="GRID">grid.24381.3c</institution-id><institution>Center for Molecular Medicine, Karolinska Institutet and Clinical Genetics, </institution><institution>Karolinska University Hospital, </institution></institution-wrap>Stockholm, Sweden </aff></contrib-group><pub-date pub-type="epub"><day>29</day><month>3</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>29</day><month>3</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>17</volume><elocation-id>91</elocation-id><history><date date-type="received"><day>11</day><month>3</month><year>2016</year></date><date date-type="accepted"><day>21</day><month>3</month><year>2017</year></date></history><permissions><copyright-statement>© The Author(s). 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title><offsets xml_i="6975" xml_f="6985" txt_i="11" txt_f="21">Background</offsets></title><p><offsets xml_i="6996" xml_f="7632" txt_i="22" txt_f="658">Vitamin D is important for bone mass accrual during growth. Additionally, it is considered a requirement for a multitude of processes associated with, for example, the development of immunity. Many countries apply vitamin D supplementation strategies in infants, but the guidelines are not based on scientific evidence and aim at prevention of rickets. It remains unclear whether the recommended doses are sufficient for the wide array of other effects of vitamin D. The VIDI trial performed in Finland is the first large randomised controlled study for evaluation of the effects of different vitamin D supplemental doses in infancy on:</offsets><list list-type="order"><list-item><p><offsets xml_i="7670" xml_f="7683" txt_i="658" txt_f="671">bone strength</offsets></p></list-item><list-item><p><offsets xml_i="7713" xml_f="7736" txt_i="672" txt_f="695">infections and immunity</offsets></p></list-item><list-item><p><offsets xml_i="7766" xml_f="7791" txt_i="696" txt_f="721">allergy, atopy and asthma</offsets></p></list-item><list-item><p><offsets xml_i="7821" xml_f="7842" txt_i="722" txt_f="743">cognitive development</offsets></p></list-item><list-item><p><offsets xml_i="7872" xml_f="7913" txt_i="744" txt_f="785">genetic regulation of mineral homeostasis</offsets></p></list-item></list><offsets xml_i="7936" xml_f="7937" txt_i="786" txt_f="787">
</offsets></p></sec><sec><title><offsets xml_i="7959" xml_f="7973" txt_i="789" txt_f="803">Methods/Design</offsets></title><p><offsets xml_i="7984" xml_f="8559" txt_i="804" txt_f="1379">VIDI, a randomised controlled double-blinded single-centre intervention study is conducted in infants from the age of 2 weeks to 24 months. Participants, recruited at Helsinki Maternity Hospital, are randomised to receive daily either 10 μg (400 IU) or 30 μg (1 200 IU) of vitamin D3 supplementation. Both groups are assessed at 6 months of age for calcium homeostasis, and at 12 and 24 months of age for parameters associated with bone strength, growth, developmental milestones, infections, immunity, atopy-related diseases, and genetic factors involved in these functions.</offsets></p></sec><sec><title><offsets xml_i="8581" xml_f="8591" txt_i="1381" txt_f="1391">Discussion</offsets></title><p><offsets xml_i="8602" xml_f="8915" txt_i="1392" txt_f="1705">The study enables evaluation of short and long term effects of supplemental vitamin D on growth, immune functions and skeletal and developmental parameters in infants, and the effects of genetic factors therein. The results enable institution of evidence-based guidelines for vitamin D supplementation in infancy.</offsets></p></sec><sec><title><offsets xml_i="8937" xml_f="8955" txt_i="1707" txt_f="1725">Trial registration</offsets></title><p><offsets xml_i="8966" xml_f="8986" txt_i="1726" txt_f="1746">ClinicalTrials.gov, </offsets><ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT01723852?term=vidi&amp;rank=1"><offsets xml_i="9098" xml_f="9109" txt_i="1746" txt_f="1757">NCT01723852</offsets></ext-link><offsets xml_i="9120" xml_f="9150" txt_i="1757" txt_f="1787">, registration date 6.11.2012.</offsets></p></sec><sec><title><offsets xml_i="9172" xml_f="9205" txt_i="1789" txt_f="1822">Electronic supplementary material</offsets></title><p><offsets xml_i="9216" xml_f="9355" txt_i="1823" txt_f="1962">The online version of this article (doi:10.1186/s12887-017-0845-5) contains supplementary material, which is available to authorized users.</offsets></p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Allergy</kwd><kwd>Asthma</kwd><kwd>Bone development</kwd><kwd>Cognitive development</kwd><kwd>Immunity</kwd><kwd>Infants</kwd><kwd>Infections</kwd><kwd>Vitamin D</kwd></kwd-group><funding-group><award-group><funding-source><institution>The Governmental Subsidy for Clinical Research</institution></funding-source></award-group><award-group><funding-source><institution>Foundation for Pediatric Research</institution></funding-source></award-group><award-group><funding-source><institution>Finska Läkaresällskapet</institution></funding-source></award-group><award-group><funding-source><institution>Folkhälsan Research Foundation</institution></funding-source></award-group><award-group><funding-source><institution>Sigrid Juselius Foundation</institution></funding-source></award-group><award-group><funding-source><institution>Emil Aaltonen Foundation</institution></funding-source></award-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010119</institution-id><institution>Stiftelsen Dorothea Olivia, Karl Walter och Jarl Walter Perkléns Minne</institution></institution-wrap></funding-source></award-group><award-group><funding-source><institution>Päivikki and Sakari Sohlberg Foundation</institution></funding-source></award-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008723</institution-id><institution>Suomen Lääketieteen Säätiö</institution></institution-wrap></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>© The Author(s) 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title><offsets xml_i="11245" xml_f="11255" txt_i="1971" txt_f="1981">Background</offsets></title><p><offsets xml_i="11266" xml_f="11301" txt_i="1982" txt_f="2017">The biologically inactive vitamin D</offsets><sub><offsets xml_i="11306" xml_f="11307" txt_i="2017" txt_f="2018">3</offsets></sub><offsets xml_i="11313" xml_f="11646" txt_i="2018" txt_f="2351"> (cholecalciferol) is produced in the skin after solar UVB exposure. It is bound to vitamin D binding protein (DBP) and transported to the liver for conversion to 25-hydroxy-vitamin D (25-OHD), the most abundant circulating metabolite of vitamin D. In the kidney, 25-OHD is further hydroxylated to the active form calcitriol, 1,25-OH</offsets><sub><offsets xml_i="11651" xml_f="11652" txt_i="2351" txt_f="2352">2</offsets></sub><offsets xml_i="11658" xml_f="11701" txt_i="2352" txt_f="2395">D, that contributes to calcium metabolism [</offsets><xref ref-type="bibr" rid="CR1"><offsets xml_i="11733" xml_f="11734" txt_i="2395" txt_f="2396">1</offsets></xref><offsets xml_i="11741" xml_f="11947" txt_i="2396" txt_f="2602">]. Paracrine conversion of 25-OHD to calcitriol occurs in many tissues, such as dendritic and endothelial cells, brain, placenta and parathyroids, underscoring the importance of vitamin D for these organs [</offsets><xref ref-type="bibr" rid="CR2"><offsets xml_i="11979" xml_f="11980" txt_i="2602" txt_f="2603">2</offsets></xref><offsets xml_i="11987" xml_f="12112" txt_i="2603" txt_f="2728">]. Based on the number of cell types expressing vitamin D receptors (VDR), 38 potential target tissues have been recognised [</offsets><xref ref-type="bibr" rid="CR3"><offsets xml_i="12144" xml_f="12145" txt_i="2728" txt_f="2729">3</offsets></xref><offsets xml_i="12152" xml_f="12287" txt_i="2729" txt_f="2864">]. In target cells, calcitriol regulates the transcription of target genes, including several genes involved in cell cycle regulation [</offsets><xref ref-type="bibr" rid="CR4"><offsets xml_i="12319" xml_f="12320" txt_i="2864" txt_f="2865">4</offsets></xref><offsets xml_i="12327" xml_f="12451" txt_i="2865" txt_f="2989">]. Locally produced calcitriol in immune cells participates in host defence reactions and acts as a potent immunomodulator [</offsets><xref ref-type="bibr" rid="CR2"><offsets xml_i="12483" xml_f="12484" txt_i="2989" txt_f="2990">2</offsets></xref><offsets xml_i="12491" xml_f="12493" txt_i="2990" txt_f="2992">, </offsets><xref ref-type="bibr" rid="CR5"><offsets xml_i="12525" xml_f="12526" txt_i="2992" txt_f="2993">5</offsets></xref><offsets xml_i="12533" xml_f="12654" txt_i="2993" txt_f="3114">]. In fact, vitamin D has been estimated to directly and indirectly regulate the expression of 2–3% of the human genome [</offsets><xref ref-type="bibr" rid="CR4"><offsets xml_i="12686" xml_f="12687" txt_i="3114" txt_f="3115">4</offsets></xref><offsets xml_i="12694" xml_f="12696" txt_i="3115" txt_f="3117">].</offsets></p><p><offsets xml_i="12703" xml_f="13042" txt_i="3118" txt_f="3457">Both cutaneously synthesised and dietary vitamin D contribute to the circulating 25-OHD concentration. There is no consensus on the optimal 25-OHD concentration. In 2011, Institute of Medicine guideline stated that 25-OHD concentrations above 50 nmol/L are required for normal body functions including linear growth and bone mass accrual [</offsets><xref ref-type="bibr" rid="CR6"><offsets xml_i="13074" xml_f="13075" txt_i="3457" txt_f="3458">6</offsets></xref><offsets xml_i="13082" xml_f="13121" txt_i="3458" txt_f="3497">]. According to the Endocrine Society [</offsets><xref ref-type="bibr" rid="CR7"><offsets xml_i="13153" xml_f="13154" txt_i="3497" txt_f="3498">7</offsets></xref><offsets xml_i="13161" xml_f="13299" txt_i="3498" txt_f="3636">], for optimizing long-term health benefits such as the prevention of diabetes or fractures, concentrations above 75 nmol/L may be needed.</offsets></p><p><offsets xml_i="13306" xml_f="13839" txt_i="3637" txt_f="4167">Vitamin D supplementation has been recommended in Finland for all infants since the 1940’s, but in line with the declining prevalence of rickets, the recommended doses have gradually decreased. The present Finnish Nutritional Council guidelines recommend 10 μg (400 IU) of vitamin D3 supplementation daily for all infants from the age of 2 weeks to 24 months, and 7.5 μg (300 IU) to children aged 2 to 18 years. Despite these recommendations, 20% of children were shown to be vitamin D deficient (&lt;50 nmol/L) at 14 months of age [</offsets><xref ref-type="bibr" rid="CR8"><offsets xml_i="13871" xml_f="13872" txt_i="4167" txt_f="4168">8</offsets></xref><offsets xml_i="13879" xml_f="14068" txt_i="4168" txt_f="4354">]. In addition, we have previously shown that more than 70% of 195 apparently healthy school children in Helsinki, Finland, were vitamin D deficient (&lt;50 nmol/L) during the school year [</offsets><xref ref-type="bibr" rid="CR9"><offsets xml_i="14100" xml_f="14101" txt_i="4354" txt_f="4355">9</offsets></xref><offsets xml_i="14108" xml_f="14110" txt_i="4355" txt_f="4357">, </offsets><xref ref-type="bibr" rid="CR10"><offsets xml_i="14143" xml_f="14145" txt_i="4357" txt_f="4359">10</offsets></xref><offsets xml_i="14152" xml_f="14154" txt_i="4359" txt_f="4361">].</offsets></p><sec id="Sec2"><title><offsets xml_i="14180" xml_f="14219" txt_i="4362" txt_f="4401">Role of vitamin D in health and disease</offsets></title><sec id="Sec3"><title><offsets xml_i="14249" xml_f="14279" txt_i="4402" txt_f="4432">Growth and bone mineralisation</offsets></title><p><offsets xml_i="14290" xml_f="14395" txt_i="4433" txt_f="4538">Serum calcium and phosphate concentrations are tightly regulated by parathyroid hormone (PTH) and 1,25-OH</offsets><sub><offsets xml_i="14400" xml_f="14401" txt_i="4538" txt_f="4539">2</offsets></sub><offsets xml_i="14407" xml_f="14586" txt_i="4539" txt_f="4718">D by negative feedback. Rickets is caused by insufficient vitamin D supply resulting in the lack of sufficient calcium and phosphate for bone mineralization at the growth plates [</offsets><xref ref-type="bibr" rid="CR11"><offsets xml_i="14619" xml_f="14621" txt_i="4718" txt_f="4720">11</offsets></xref><offsets xml_i="14628" xml_f="14681" txt_i="4720" txt_f="4773">]. The worldwide incidence of rickets is increasing [</offsets><xref ref-type="bibr" rid="CR11"><offsets xml_i="14714" xml_f="14716" txt_i="4773" txt_f="4775">11</offsets></xref><offsets xml_i="14723" xml_f="14879" txt_i="4775" txt_f="4931">]. Vitamin D deficiency is associated with low bone mineral density (BMD) and an unfavourable bone development in children aged 6–16 years and in newborns [</offsets><xref ref-type="bibr" rid="CR12"><offsets xml_i="14912" xml_f="14914" txt_i="4931" txt_f="4933">12</offsets></xref><offsets xml_i="14921" xml_f="14923" txt_i="4933" txt_f="4935">, </offsets><xref ref-type="bibr" rid="CR13"><offsets xml_i="14956" xml_f="14958" txt_i="4935" txt_f="4937">13</offsets></xref><offsets xml_i="14965" xml_f="15197" txt_i="4937" txt_f="5169">]. However, data on the relationship between vitamin D and BMD in children are somewhat contradictory. In healthy children aged 8–17 years with S-25-OHD levels above 50 nmol/L, no effect of vitamin D supplementation on BMD is seen [</offsets><xref ref-type="bibr" rid="CR14"><offsets xml_i="15230" xml_f="15232" txt_i="5169" txt_f="5171">14</offsets></xref><offsets xml_i="15239" xml_f="15335" txt_i="5171" txt_f="5267">], and the relationship between BMD and S-25-OHD is inconsistent in infants and young children [</offsets><xref ref-type="bibr" rid="CR15"><offsets xml_i="15368" xml_f="15370" txt_i="5267" txt_f="5269">15</offsets></xref><offsets xml_i="15377" xml_f="15379" txt_i="5269" txt_f="5271">].</offsets></p><p><offsets xml_i="15386" xml_f="15540" txt_i="5272" txt_f="5423">In infants, severe vitamin D deficiency (&lt;25 nmol/L) associates with poor linear growth and delayed motor development possibly due to muscle weakness [</offsets><xref ref-type="bibr" rid="CR16"><offsets xml_i="15573" xml_f="15575" txt_i="5423" txt_f="5425">16</offsets></xref><offsets xml_i="15582" xml_f="15584" txt_i="5425" txt_f="5427">, </offsets><xref ref-type="bibr" rid="CR17"><offsets xml_i="15617" xml_f="15619" txt_i="5427" txt_f="5429">17</offsets></xref><offsets xml_i="15626" xml_f="15743" txt_i="5429" txt_f="5546">]. In vitamin D deficient children, vitamin D supplementation improved growth velocity and prevented stunted growth [</offsets><xref ref-type="bibr" rid="CR18"><offsets xml_i="15776" xml_f="15778" txt_i="5546" txt_f="5548">18</offsets></xref><offsets xml_i="15785" xml_f="15787" txt_i="5548" txt_f="5550">, </offsets><xref ref-type="bibr" rid="CR19"><offsets xml_i="15820" xml_f="15822" txt_i="5550" txt_f="5552">19</offsets></xref><offsets xml_i="15829" xml_f="15906" txt_i="5552" txt_f="5629">]. The increase in S-25-OHD concentration increased circulating IGF-1 level [</offsets><xref ref-type="bibr" rid="CR18"><offsets xml_i="15939" xml_f="15941" txt_i="5629" txt_f="5631">18</offsets></xref><offsets xml_i="15948" xml_f="15950" txt_i="5631" txt_f="5633">].</offsets></p></sec><sec id="Sec4"><title><offsets xml_i="15982" xml_f="16005" txt_i="5635" txt_f="5658">Infections and immunity</offsets></title><p><offsets xml_i="16016" xml_f="16117" txt_i="5659" txt_f="5760">Rickets commonly presents with comorbidities such as continuous or recurrent respiratory infections [</offsets><xref ref-type="bibr" rid="CR20"><offsets xml_i="16150" xml_f="16152" txt_i="5760" txt_f="5762">20</offsets></xref><offsets xml_i="16159" xml_f="16161" txt_i="5762" txt_f="5764">, </offsets><xref ref-type="bibr" rid="CR21"><offsets xml_i="16194" xml_f="16196" txt_i="5764" txt_f="5766">21</offsets></xref><offsets xml_i="16203" xml_f="16397" txt_i="5766" txt_f="5960">]. Vitamin D has profound effects on the immune system by promoting immune responses and inducing innate immune defences. Immune cells express vitamin D receptor (VDR) and respond to vitamin D [</offsets><xref ref-type="bibr" rid="CR22"><offsets xml_i="16430" xml_f="16432" txt_i="5960" txt_f="5962">22</offsets></xref><offsets xml_i="16439" xml_f="16441" txt_i="5962" txt_f="5964">, </offsets><xref ref-type="bibr" rid="CR23"><offsets xml_i="16474" xml_f="16476" txt_i="5964" txt_f="5966">23</offsets></xref><offsets xml_i="16483" xml_f="16881" txt_i="5966" txt_f="6364">]. On innate immunity, vitamin D inhibits the expression of pattern-recognition receptors, induces autophagy in macrophages and induces endogenous antimicrobial peptides, such as cathelicidin. On adaptive immunity, for example, vitamin D acts by regulating the release of pro-inflammatory cytokines from mononuclear cells and inhibits T-cell proliferation through decreased Th1 cytokine secretion [</offsets><xref ref-type="bibr" rid="CR24"><offsets xml_i="16914" xml_f="16916" txt_i="6364" txt_f="6366">24</offsets></xref><offsets xml_i="16923" xml_f="16924" txt_i="6366" txt_f="6367">–</offsets><xref ref-type="bibr" rid="CR26"><offsets xml_i="16957" xml_f="16959" txt_i="6367" txt_f="6369">26</offsets></xref><offsets xml_i="16966" xml_f="17133" txt_i="6369" txt_f="6536">]. Therefore, vitamin D does not only have a role in modulating host defence to infections, but is likely to control factors in autoimmunity, also in allergic disease.</offsets></p><p><offsets xml_i="17140" xml_f="17208" txt_i="6537" txt_f="6605">Vitamin D modifies response to both bacterial and viral infections [</offsets><xref ref-type="bibr" rid="CR24"><offsets xml_i="17241" xml_f="17243" txt_i="6605" txt_f="6607">24</offsets></xref><offsets xml_i="17250" xml_f="17252" txt_i="6607" txt_f="6609">, </offsets><xref ref-type="bibr" rid="CR27"><offsets xml_i="17285" xml_f="17287" txt_i="6609" txt_f="6611">27</offsets></xref><offsets xml_i="17294" xml_f="17373" txt_i="6611" txt_f="6690">]. In adults, vitamin D insufficiency increases the risk of severe infections [</offsets><xref ref-type="bibr" rid="CR28"><offsets xml_i="17406" xml_f="17408" txt_i="6690" txt_f="6692">28</offsets></xref><offsets xml_i="17415" xml_f="17476" txt_i="6692" txt_f="6753">], but the results from intervention trials are conflicting [</offsets><xref ref-type="bibr" rid="CR29"><offsets xml_i="17509" xml_f="17511" txt_i="6753" txt_f="6755">29</offsets></xref><offsets xml_i="17518" xml_f="17632" txt_i="6755" txt_f="6869">]. Vitamin D deficiency may contribute to increased occurrence of lower respiratory tract infections in children [</offsets><xref ref-type="bibr" rid="CR30"><offsets xml_i="17665" xml_f="17667" txt_i="6869" txt_f="6871">30</offsets></xref><offsets xml_i="17674" xml_f="17844" txt_i="6871" txt_f="7041">]. In 167 Japanese children aged 6–16 years a supplemental vitamin D3 of 1 200 IU for a period of 4 months resulted in a significant reduction in influenza A infections [</offsets><xref ref-type="bibr" rid="CR31"><offsets xml_i="17877" xml_f="17879" txt_i="7041" txt_f="7043">31</offsets></xref><offsets xml_i="17886" xml_f="18016" txt_i="7043" txt_f="7173">]. In addition, vitamin D deficiency is associated with upper respiratory tract, gastrointestinal and ear infections in children [</offsets><xref ref-type="bibr" rid="CR32"><offsets xml_i="18049" xml_f="18051" txt_i="7173" txt_f="7175">32</offsets></xref><offsets xml_i="18058" xml_f="18060" txt_i="7175" txt_f="7177">, </offsets><xref ref-type="bibr" rid="CR33"><offsets xml_i="18093" xml_f="18095" txt_i="7177" txt_f="7179">33</offsets></xref><offsets xml_i="18102" xml_f="18256" txt_i="7179" txt_f="7333">]. Identification, treatment, and prevention of vitamin D deficiency in early childhood may therefore have widespread health effects throughout childhood.</offsets></p></sec><sec id="Sec5"><title><offsets xml_i="18288" xml_f="18313" txt_i="7335" txt_f="7360">Allergy, atopy and asthma</offsets></title><p><offsets xml_i="18324" xml_f="18399" txt_i="7361" txt_f="7436">In Finland, the prevalence of asthma among children aged 7–16 years is 7% [</offsets><xref ref-type="bibr" rid="CR34"><offsets xml_i="18432" xml_f="18434" txt_i="7436" txt_f="7438">34</offsets></xref><offsets xml_i="18441" xml_f="18701" txt_i="7438" txt_f="7698">]. Based on epidemiological studies, low maternal intake of vitamin D at pregnancy and low cord blood 25-OHD concentration have been associated with a higher risk for asthma, allergic rhinitis and atopic eczema in the offspring, as assessed at 5 years of age [</offsets><xref ref-type="bibr" rid="CR35"><offsets xml_i="18734" xml_f="18736" txt_i="7698" txt_f="7700">35</offsets></xref><offsets xml_i="18743" xml_f="18744" txt_i="7700" txt_f="7701">–</offsets><xref ref-type="bibr" rid="CR38"><offsets xml_i="18777" xml_f="18779" txt_i="7701" txt_f="7703">38</offsets></xref><offsets xml_i="18786" xml_f="18833" txt_i="7703" txt_f="7750">]. However, findings have not been consistent [</offsets><xref ref-type="bibr" rid="CR39"><offsets xml_i="18866" xml_f="18868" txt_i="7750" txt_f="7752">39</offsets></xref><offsets xml_i="18875" xml_f="18997" txt_i="7752" txt_f="7874">] and recent studies on prenatal vitamin D supplementation have not demonstrated an effect on wheezing at 3 years of age [</offsets><xref ref-type="bibr" rid="CR40"><offsets xml_i="19030" xml_f="19032" txt_i="7874" txt_f="7876">40</offsets></xref><offsets xml_i="19039" xml_f="19041" txt_i="7876" txt_f="7878">, </offsets><xref ref-type="bibr" rid="CR41"><offsets xml_i="19074" xml_f="19076" txt_i="7878" txt_f="7880">41</offsets></xref><offsets xml_i="19083" xml_f="19208" txt_i="7880" txt_f="8005">]. Vitamin D may, however, have a protective effect against childhood wheezing and asthma, but the evidence is inconclusive [</offsets><xref ref-type="bibr" rid="CR42"><offsets xml_i="19241" xml_f="19243" txt_i="8005" txt_f="8007">42</offsets></xref><offsets xml_i="19250" xml_f="19375" txt_i="8007" txt_f="8132">]. In adults, IgE concentrations are higher for those adults with low or very high concentration of serum 25-OHD (S-25-OHD) [</offsets><xref ref-type="bibr" rid="CR43"><offsets xml_i="19408" xml_f="19410" txt_i="8132" txt_f="8134">43</offsets></xref><offsets xml_i="19417" xml_f="19419" txt_i="8134" txt_f="8136">].</offsets></p></sec><sec id="Sec6"><title><offsets xml_i="19451" xml_f="19472" txt_i="8138" txt_f="8159">Cognitive development</offsets></title><p><offsets xml_i="19483" xml_f="19623" txt_i="8160" txt_f="8300">The association between concentrations of S-25-OHD and cognitive abilities has been widely studied among middle-aged and older individuals [</offsets><xref ref-type="bibr" rid="CR44"><offsets xml_i="19656" xml_f="19658" txt_i="8300" txt_f="8302">44</offsets></xref><offsets xml_i="19665" xml_f="19666" txt_i="8302" txt_f="8303">–</offsets><xref ref-type="bibr" rid="CR46"><offsets xml_i="19699" xml_f="19701" txt_i="8303" txt_f="8305">46</offsets></xref><offsets xml_i="19708" xml_f="19861" txt_i="8305" txt_f="8458">]. Vitamin D trials are rare and they have not been able to support beneficial effects of vitamin D supplementation on cognitive functions among adults [</offsets><xref ref-type="bibr" rid="CR47"><offsets xml_i="19894" xml_f="19896" txt_i="8458" txt_f="8460">47</offsets></xref><offsets xml_i="19903" xml_f="19905" txt_i="8460" txt_f="8462">, </offsets><xref ref-type="bibr" rid="CR48"><offsets xml_i="19938" xml_f="19940" txt_i="8462" txt_f="8464">48</offsets></xref><offsets xml_i="19947" xml_f="20235" txt_i="8464" txt_f="8752">]. Little evidence exists on the effects of vitamin D on the cognitive development among children and adolescents. Low concentrations of cord blood 25-OHD increased the risk for delayed mental and psychomotor development in 363 16–18-months-old children with severe vitamin D deficiency [</offsets><xref ref-type="bibr" rid="CR49"><offsets xml_i="20268" xml_f="20270" txt_i="8752" txt_f="8754">49</offsets></xref><offsets xml_i="20277" xml_f="20522" txt_i="8754" txt_f="8999">]. Surprisingly, also the children with the highest S-25-OHD concentrations had deficits in psychomotor development. However, S-25-OHD concentrations were not associated with cognitive performance in adolescents after controlling for ethnicity [</offsets><xref ref-type="bibr" rid="CR50"><offsets xml_i="20555" xml_f="20557" txt_i="8999" txt_f="9001">50</offsets></xref><offsets xml_i="20564" xml_f="20565" txt_i="9001" txt_f="9002">–</offsets><xref ref-type="bibr" rid="CR52"><offsets xml_i="20598" xml_f="20600" txt_i="9002" txt_f="9004">52</offsets></xref><offsets xml_i="20607" xml_f="20789" txt_i="9004" txt_f="9186">]. Although preliminary results point to importance of early life exposure, the role of vitamin D in cognitive development during childhood and adolescence remains largely unstudied.</offsets></p></sec><sec id="Sec7"><title><offsets xml_i="20821" xml_f="20862" txt_i="9188" txt_f="9229">Genetic regulation of mineral homeostasis</offsets></title><p><offsets xml_i="20873" xml_f="20998" txt_i="9230" txt_f="9355">S-25-OHD concentration has high heritability (28–80%), which explains differences in responses to vitamin D supplementation [</offsets><xref ref-type="bibr" rid="CR53"><offsets xml_i="21031" xml_f="21033" txt_i="9355" txt_f="9357">53</offsets></xref><offsets xml_i="21040" xml_f="21217" txt_i="9357" txt_f="9534">]. Genome-wide association studies on vitamin D insufficiency identified a number of common genetic variants that influence 25-OHD concentrations and the risk of insufficiency [</offsets><xref ref-type="bibr" rid="CR54"><offsets xml_i="21250" xml_f="21252" txt_i="9534" txt_f="9536">54</offsets></xref><offsets xml_i="21259" xml_f="21619" txt_i="9536" txt_f="9896">]. These included single nucleotide polymorphisms in the GC gene encoding vitamin D binding protein, locus near the 7-dehydrocholesterol reductase involved in vitamin D synthesis in the skin, and CYP2R1 coding cytochrome P450 responsible for 25-hydroxylation. We have studied GC polymorphisms in relation to vitamin D metabolism and bone strength in children [</offsets><xref ref-type="bibr" rid="CR55"><offsets xml_i="21652" xml_f="21654" txt_i="9896" txt_f="9898">55</offsets></xref><offsets xml_i="21661" xml_f="21995" txt_i="9898" txt_f="10232">] and observed differences in S-25-OHD and PTH concentrations between GC genotypes and that variation exists in BMD and bone strength index as well. The variation in S-25-OHD between GC genotypes suggests differences in vitamin D utilisation. Polymorphisms of the vitamin D receptor gene VDR associate with growth pattern in infancy [</offsets><xref ref-type="bibr" rid="CR56"><offsets xml_i="22028" xml_f="22030" txt_i="10232" txt_f="10234">56</offsets></xref><offsets xml_i="22037" xml_f="22039" txt_i="10234" txt_f="10236">, </offsets><xref ref-type="bibr" rid="CR57"><offsets xml_i="22072" xml_f="22074" txt_i="10236" txt_f="10238">57</offsets></xref><offsets xml_i="22081" xml_f="22107" txt_i="10238" txt_f="10264">] and with bone strength [</offsets><xref ref-type="bibr" rid="CR58"><offsets xml_i="22140" xml_f="22142" txt_i="10264" txt_f="10266">58</offsets></xref><offsets xml_i="22149" xml_f="22405" txt_i="10266" txt_f="10522">]. VDR polymorphisms together with vitamin D supplementation affect bone mineral accrual suggesting that vitamin D supplementation could be used to change the developmental trajectory and induce phenotype with lowered risk for chronic disease or disorder [</offsets><xref ref-type="bibr" rid="CR59"><offsets xml_i="22438" xml_f="22440" txt_i="10522" txt_f="10524">59</offsets></xref><offsets xml_i="22447" xml_f="22449" txt_i="10524" txt_f="10526">, </offsets><xref ref-type="bibr" rid="CR60"><offsets xml_i="22482" xml_f="22484" txt_i="10526" txt_f="10528">60</offsets></xref><offsets xml_i="22491" xml_f="22621" txt_i="10528" txt_f="10658">]. Other possible candidate genes include CYP24A1 that encodes 24-hydroxylase initiating degradation of both 25-OHD and 1,25-OHD [</offsets><xref ref-type="bibr" rid="CR54"><offsets xml_i="22654" xml_f="22656" txt_i="10658" txt_f="10660">54</offsets></xref><offsets xml_i="22663" xml_f="22665" txt_i="10660" txt_f="10662">].</offsets></p></sec></sec><sec id="Sec8"><title><offsets xml_i="22703" xml_f="22738" txt_i="10665" txt_f="10700">Overall aims and research questions</offsets></title><p><offsets xml_i="22749" xml_f="22904" txt_i="10701" txt_f="10856">The aim of the study is to investigate long-term health benefits of early vitamin D supplementation with a dose ensuring effective concentration of 25-OHD.</offsets></p><p><offsets xml_i="22911" xml_f="23195" txt_i="10857" txt_f="11141">The primary outcomes of the study are bone strength and cumulative frequency of infections at 24 months of age. We hypothesise that a higher vitamin D supplementation to infants between 2 weeks and 24 months of age will increase bone strength and decrease the frequency of infections.</offsets></p><p><offsets xml_i="23202" xml_f="23484" txt_i="11142" txt_f="11424">Secondary outcomes of the study are occurrence of IgE mediated allergic symptoms, growth, motor, cognitive and social development, and associations of concentration and effects of vitamin D with polymorphisms of genes associated with its synthesis, binding proteins and degradation.</offsets></p></sec></sec><sec id="Sec9" sec-type="materials|methods"><title><offsets xml_i="23551" xml_f="23565" txt_i="11427" txt_f="11441">Methods/Design</offsets></title><sec id="Sec10"><title><offsets xml_i="23596" xml_f="23620" txt_i="11442" txt_f="11466">Study design and setting</offsets></title><p><offsets xml_i="23631" xml_f="23755" txt_i="11467" txt_f="11591">This is a randomised on-going controlled double-blinded intervention trial on children of 2 weeks to 24 months of age (Fig. </offsets><xref rid="Fig1" ref-type="fig"><offsets xml_i="23787" xml_f="23788" txt_i="11591" txt_f="11592">1</offsets></xref><offsets xml_i="23795" xml_f="23893" txt_i="11592" txt_f="11690">). Vitamin D supplementation was commenced at 2 weeks of age and continued until 24 months of age.</offsets><fig id="Fig1"><label><offsets xml_i="23915" xml_f="23921" txt_i="11690" txt_f="11696">Fig. 1</offsets></label><caption><p><offsets xml_i="23941" xml_f="23985" txt_i="11696" txt_f="11740">Study protocol. Methods are listed in Table </offsets><xref rid="Tab1" ref-type="table"><offsets xml_i="24019" xml_f="24020" txt_i="11740" txt_f="11741">1</offsets></xref><offsets xml_i="24027" xml_f="24077" txt_i="11741" txt_f="11791"> and further described in Additional documentation</offsets></p></caption><graphic xlink:href="12887_2017_845_Fig1_HTML" id="MO1"></graphic></fig><offsets xml_i="24163" xml_f="24164" txt_i="11792" txt_f="11793">
</offsets></p><p><offsets xml_i="24171" xml_f="24468" txt_i="11794" txt_f="12091">This study is carried out at the Kätilöopisto Maternity Hospital, Helsinki, Finland (60°20,40’N). The hospital is one of three hospitals providing maternity services for the greater Helsinki area (a population of 1.5 million) with 8 000 births annually (15 000 in the whole greater Helsinki area).</offsets></p></sec><sec id="Sec11"><title><offsets xml_i="24501" xml_f="24514" txt_i="12093" txt_f="12106">Research team</offsets></title><p><offsets xml_i="24525" xml_f="24894" txt_i="12107" txt_f="12476">The research team responsible for inception, implementation, and management of the protocol includes paediatricians, paediatric specialists in the field of neonatology, endocrinology, infectious diseases and immunology, psychologists, and nutritionists. The research team and the research nurses undertake recruitment, data collection, follow-up visits, and data entry.</offsets></p></sec><sec id="Sec12"><title><offsets xml_i="24927" xml_f="24953" txt_i="12478" txt_f="12504">Procedure and participants</offsets></title><p><offsets xml_i="24964" xml_f="25315" txt_i="12505" txt_f="12856">A total of 4 980 infants were assessed for eligibility and 1 572 did not meet the inclusion criteria. Written information of the study was given to 3 408 families at the Helsinki Maternity Hospital 1–2 days after delivery from which 2 421 declined to participate. Altogether 987 healthy term newborns were recruited between January 2013 and June 2014.</offsets></p><p><offsets xml_i="25322" xml_f="25880" txt_i="12857" txt_f="13415">The participating mothers were of Caucasian origin, without regular medication and with a singleton pregnancy. The infants were born at term (37 + 0 to 42 + 0 weeks) with a birth weight appropriate for gestational age (birth weight SD score between −2.0 to +2.0). Exclusion criteria for the infants were nasal continuous positive airway pressure treatment for more than 1 day, intravenous glucose infusion, intravenous postnatal antibiotic treatment, seizures, duration of phototherapy for more than 3 days, and need for nasogastric tube for more than 1 day.</offsets></p><p><offsets xml_i="25887" xml_f="26162" txt_i="13416" txt_f="13691">Girls (492) and boys (495) were randomised at recruitment in blocks of 50 to receive either 10 or 30 μg of vitamin D3 (400 IU or 1 200 IU, respectively) daily during the study period. Randomisation was performed by an external pharmacist and was blinded from the study group.</offsets></p><p><offsets xml_i="26169" xml_f="26387" txt_i="13692" txt_f="13910">Vitamin D is administered once daily with 5 drops for both concentrations. The families received a study diary to record treatment compliance prospectively and empty vitamin D bottles are collected at follow-up visits.</offsets></p><p><offsets xml_i="26394" xml_f="27073" txt_i="13911" txt_f="14590">Each family keep record of the child’s infections on a study diary throughout the study period. Data on allergic symptoms, growth, child’s motor and neurocognitive functioning, mental and behavioural health, social skills, sleep and diet are also collected. Furthermore, mothers report their own well-being at child’s birth (questionnaires given at recruitment) and at 12- and 24-month follow-up. Follow-up visits for the children are arranged at 6, 12 and 24 months of age at which blood samples are taken. Bone strength is measured with peripheral quantitative computer tomography (pQCT) at 12 and 24-month follow-up visits (overview of study follow-up and parameters in Table </offsets><xref rid="Tab1" ref-type="table"><offsets xml_i="27107" xml_f="27108" txt_i="14590" txt_f="14591">1</offsets></xref><offsets xml_i="27115" xml_f="27221" txt_i="14591" txt_f="14697">). During the visit the families meet a study nurse and have the possibility to meet with a paediatrician.</offsets><table-wrap id="Tab1"><label><offsets xml_i="27250" xml_f="27257" txt_i="14697" txt_f="14704">Table 1</offsets></label><caption><p><offsets xml_i="27277" xml_f="27370" txt_i="14704" txt_f="14797">Methods and timing of sampling. Methods are characterised further in Additional documentation</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th></th><th><offsets xml_i="27445" xml_f="27450" txt_i="14798" txt_f="14803">Birth</offsets></th><th><offsets xml_i="27459" xml_f="27474" txt_i="14803" txt_f="14818">6 months of age</offsets></th><th><offsets xml_i="27483" xml_f="27499" txt_i="14818" txt_f="14834">12 months of age</offsets></th><th><offsets xml_i="27508" xml_f="27524" txt_i="14834" txt_f="14850">24 months of age</offsets></th></tr></thead><tbody><tr><td><offsets xml_i="27557" xml_f="27566" txt_i="14850" txt_f="14859">Vitamin D</offsets></td><td><offsets xml_i="27575" xml_f="27576" txt_i="14860" txt_f="14861">x</offsets></td><td></td><td><offsets xml_i="27594" xml_f="27595" txt_i="14863" txt_f="14864">x</offsets></td><td><offsets xml_i="27604" xml_f="27605" txt_i="14865" txt_f="14866">x</offsets></td></tr><tr><td><offsets xml_i="27623" xml_f="27650" txt_i="14867" txt_f="14894">Calcium and bone metabolism</offsets></td><td><offsets xml_i="27659" xml_f="27660" txt_i="14895" txt_f="14896">x</offsets></td><td><offsets xml_i="27669" xml_f="27670" txt_i="14897" txt_f="14898">x</offsets></td><td><offsets xml_i="27679" xml_f="27680" txt_i="14899" txt_f="14900">x</offsets></td><td><offsets xml_i="27689" xml_f="27690" txt_i="14901" txt_f="14902">x</offsets></td></tr><tr><td><offsets xml_i="27708" xml_f="27728" txt_i="14903" txt_f="14923">Inflammatory markers</offsets></td><td><offsets xml_i="27737" xml_f="27738" txt_i="14924" txt_f="14925">x</offsets></td><td></td><td><offsets xml_i="27756" xml_f="27757" txt_i="14927" txt_f="14928">x</offsets></td><td><offsets xml_i="27766" xml_f="27767" txt_i="14929" txt_f="14930">x</offsets></td></tr><tr><td><offsets xml_i="27785" xml_f="27788" txt_i="14931" txt_f="14934">DNA</offsets></td><td><offsets xml_i="27797" xml_f="27798" txt_i="14935" txt_f="14936">x</offsets></td><td></td><td><offsets xml_i="27816" xml_f="27817" txt_i="14938" txt_f="14939">x</offsets></td><td><offsets xml_i="27826" xml_f="27827" txt_i="14940" txt_f="14941">x</offsets></td></tr><tr><td><offsets xml_i="27845" xml_f="27862" txt_i="14942" txt_f="14959">Bone densitometry</offsets></td><td></td><td></td><td><offsets xml_i="27889" xml_f="27890" txt_i="14962" txt_f="14963">x</offsets></td><td><offsets xml_i="27899" xml_f="27900" txt_i="14964" txt_f="14965">x</offsets></td></tr><tr><td><offsets xml_i="27918" xml_f="27935" txt_i="14966" txt_f="14983">Infection records</offsets></td><td></td><td><offsets xml_i="27953" xml_f="27954" txt_i="14985" txt_f="14986">x</offsets></td><td><offsets xml_i="27963" xml_f="27964" txt_i="14987" txt_f="14988">x</offsets></td><td><offsets xml_i="27973" xml_f="27974" txt_i="14989" txt_f="14990">x</offsets></td></tr><tr><td><offsets xml_i="27992" xml_f="28013" txt_i="14991" txt_f="15012">Allergy questionnaire</offsets></td><td></td><td><offsets xml_i="28031" xml_f="28032" txt_i="15014" txt_f="15015">x</offsets></td><td><offsets xml_i="28041" xml_f="28042" txt_i="15016" txt_f="15017">x</offsets></td><td><offsets xml_i="28051" xml_f="28052" txt_i="15018" txt_f="15019">x</offsets></td></tr><tr><td><offsets xml_i="28070" xml_f="28108" txt_i="15020" txt_f="15058">Specific allergic responses (IgA, IgE)</offsets></td><td></td><td></td><td><offsets xml_i="28135" xml_f="28136" txt_i="15061" txt_f="15062">x</offsets></td><td><offsets xml_i="28145" xml_f="28146" txt_i="15063" txt_f="15064">x</offsets></td></tr><tr><td><offsets xml_i="28164" xml_f="28175" txt_i="15065" txt_f="15076">Iron status</offsets></td><td></td><td></td><td><offsets xml_i="28202" xml_f="28203" txt_i="15079" txt_f="15080">x</offsets></td><td><offsets xml_i="28212" xml_f="28213" txt_i="15081" txt_f="15082">x</offsets></td></tr><tr><td><offsets xml_i="28231" xml_f="28245" txt_i="15083" txt_f="15097">Dietary survey</offsets></td><td><offsets xml_i="28254" xml_f="28255" txt_i="15098" txt_f="15099">x</offsets><sup><offsets xml_i="28260" xml_f="28261" txt_i="15099" txt_f="15100">a</offsets></sup><offsets xml_i="28267" xml_f="28268" txt_i="15100" txt_f="15101">
</offsets></td><td><offsets xml_i="28277" xml_f="28278" txt_i="15102" txt_f="15103">x</offsets></td><td><offsets xml_i="28287" xml_f="28288" txt_i="15104" txt_f="15105">x</offsets></td><td><offsets xml_i="28297" xml_f="28298" txt_i="15106" txt_f="15107">x</offsets></td></tr><tr><td><offsets xml_i="28316" xml_f="28335" txt_i="15108" txt_f="15127">Neurological scales</offsets></td><td></td><td></td><td><offsets xml_i="28362" xml_f="28363" txt_i="15130" txt_f="15131">x</offsets></td><td><offsets xml_i="28372" xml_f="28373" txt_i="15132" txt_f="15133">x</offsets></td></tr><tr><td><offsets xml_i="28391" xml_f="28428" txt_i="15134" txt_f="15171">Family sociodemographic and lifestyle</offsets></td><td><offsets xml_i="28437" xml_f="28438" txt_i="15172" txt_f="15173">x</offsets></td><td></td><td></td><td><offsets xml_i="28465" xml_f="28466" txt_i="15176" txt_f="15177">x</offsets></td></tr><tr><td><offsets xml_i="28484" xml_f="28517" txt_i="15178" txt_f="15211">Neurocognitive development scales</offsets></td><td></td><td></td><td><offsets xml_i="28544" xml_f="28545" txt_i="15214" txt_f="15215">x</offsets></td><td><offsets xml_i="28554" xml_f="28555" txt_i="15216" txt_f="15217">x</offsets></td></tr><tr><td><offsets xml_i="28573" xml_f="28600" txt_i="15218" txt_f="15245">Mental health and behaviour</offsets></td><td><offsets xml_i="28609" xml_f="28610" txt_i="15246" txt_f="15247">x</offsets></td><td></td><td><offsets xml_i="28628" xml_f="28629" txt_i="15249" txt_f="15250">x</offsets></td><td><offsets xml_i="28638" xml_f="28639" txt_i="15251" txt_f="15252">x</offsets></td></tr><tr><td><offsets xml_i="28657" xml_f="28676" txt_i="15253" txt_f="15272">Clinical assessment</offsets></td><td></td><td><offsets xml_i="28694" xml_f="28695" txt_i="15274" txt_f="15275">x</offsets></td><td><offsets xml_i="28704" xml_f="28705" txt_i="15276" txt_f="15277">x</offsets></td><td><offsets xml_i="28714" xml_f="28715" txt_i="15278" txt_f="15279">x</offsets></td></tr><tr><td><offsets xml_i="28733" xml_f="28747" txt_i="15280" txt_f="15294">Health records</offsets></td><td><offsets xml_i="28756" xml_f="28757" txt_i="15295" txt_f="15296">x</offsets></td><td><offsets xml_i="28766" xml_f="28767" txt_i="15297" txt_f="15298">x</offsets></td><td><offsets xml_i="28776" xml_f="28777" txt_i="15299" txt_f="15300">x</offsets></td><td><offsets xml_i="28786" xml_f="28787" txt_i="15301" txt_f="15302">x</offsets></td></tr><tr><td><offsets xml_i="28805" xml_f="28829" txt_i="15303" txt_f="15327">Viral and bacterial swab</offsets></td><td></td><td></td><td><offsets xml_i="28856" xml_f="28857" txt_i="15330" txt_f="15331">x</offsets></td><td><offsets xml_i="28866" xml_f="28867" txt_i="15332" txt_f="15333">x</offsets></td></tr></tbody></table><table-wrap-foot><p><offsets xml_i="28913" xml_f="28914" txt_i="15334" txt_f="15335">
</offsets><sup><offsets xml_i="28919" xml_f="28920" txt_i="15335" txt_f="15336">a</offsets></sup><offsets xml_i="28926" xml_f="28958" txt_i="15336" txt_f="15368">retrospectively on maternal diet</offsets></p></table-wrap-foot></table-wrap><offsets xml_i="28993" xml_f="28994" txt_i="15369" txt_f="15370">
</offsets></p><p><offsets xml_i="29001" xml_f="29248" txt_i="15371" txt_f="15618">A total of 875 participants have been to their 12-month follow-up visit (a drop-out of 112 children) and the 24-month follow-up visits are ongoing (to date, parents of 36 children have declined to participate in the 24-month follow-up visit, Fig. </offsets><xref rid="Fig2" ref-type="fig"><offsets xml_i="29280" xml_f="29281" txt_i="15618" txt_f="15619">2</offsets></xref><offsets xml_i="29288" xml_f="29290" txt_i="15619" txt_f="15621">).</offsets><fig id="Fig2"><label><offsets xml_i="29312" xml_f="29318" txt_i="15621" txt_f="15627">Fig. 2</offsets></label><caption><p><offsets xml_i="29338" xml_f="29398" txt_i="15627" txt_f="15687">Study recruitment, adherence, and current phase of the study</offsets></p></caption><graphic xlink:href="12887_2017_845_Fig2_HTML" id="MO2"></graphic></fig><offsets xml_i="29484" xml_f="29485" txt_i="15688" txt_f="15689">
</offsets></p></sec><sec id="Sec13"><title><offsets xml_i="29518" xml_f="29540" txt_i="15691" txt_f="15713">Ethical considerations</offsets></title><p><offsets xml_i="29551" xml_f="29732" txt_i="15714" txt_f="15895">An informed consent was obtained from the parents at recruitment. Previous intervention studies have evaluated the safety of substitution doses of up to 50 μg vitamin D in infants [</offsets><xref ref-type="bibr" rid="CR61"><offsets xml_i="29765" xml_f="29767" txt_i="15895" txt_f="15897">61</offsets></xref><offsets xml_i="29774" xml_f="29964" txt_i="15897" txt_f="16087">]. Safety was ensured by performing a pilot study for the proposed project: 113 children were randomised into three groups receiving vitamin D3 doses of 10, 30 and 40 μg daily for 3 months [</offsets><xref ref-type="bibr" rid="CR62"><offsets xml_i="29997" xml_f="29999" txt_i="16087" txt_f="16089">62</offsets></xref><offsets xml_i="30006" xml_f="30540" txt_i="16089" txt_f="16623">]. No hypercalcemia was observed in this study. Plasma and urine calcium concentrations did not differ between the three groups and in all groups the mean concentration of S-25-OHD reached at least 80 nmol/L, which was considered sufficient. Therefore, 10 μg a day was considered adequate and ethically sound to use as the dosage for the control group. While the group receiving 40 μg/day did not develop hypercalcaemia, their S-25-OHD reached levels higher than targeted. Dose of 30 μg/day was therefore chosen for the present study.</offsets></p><p><offsets xml_i="30547" xml_f="30638" txt_i="16624" txt_f="16715">An external steering group was recruited to monitor the study and possible adverse effects.</offsets></p><p><offsets xml_i="30645" xml_f="30778" txt_i="16716" txt_f="16849">The vitamin D3 supplements are prepared by Orion Pharmaceuticals (Espoo, Finland). The study is researcher initiated and independent.</offsets></p><p><offsets xml_i="30785" xml_f="30956" txt_i="16850" txt_f="17021">The Research Ethics Committee of the Hospital District of Helsinki and Uusimaa has approved the study (ID 107/13/03/03/2012) and it is registered into ClinicalTrials.com (</offsets><ext-link ext-link-type="uri" xlink:href="http://www.clinicaltrials.gov/NCT01723852"><offsets xml_i="31041" xml_f="31052" txt_i="17021" txt_f="17032">NCT01723852</offsets></ext-link><offsets xml_i="31063" xml_f="31065" txt_i="17032" txt_f="17034">).</offsets></p></sec><sec id="Sec14"><title><offsets xml_i="31098" xml_f="31112" txt_i="17036" txt_f="17050">Study measures</offsets></title><p><offsets xml_i="31123" xml_f="31173" txt_i="17051" txt_f="17101">An overview of study parameters is shown in Table </offsets><xref rid="Tab1" ref-type="table"><offsets xml_i="31207" xml_f="31208" txt_i="17101" txt_f="17102">1</offsets></xref><offsets xml_i="31215" xml_f="31619" txt_i="17102" txt_f="17506">. A full description of specific methods used in the study are presented in the online Additional documentation. In brief, the parameters used for the assessment of primary outcomes are as follows: bone parameters assessed with pQCT at 12 and 24 months of age, daily infection diary filled in by parents from 2 weeks to 24 months of age, and S-25-OHD at birth (cord blood) and at 12 and 24 months of age.</offsets></p></sec><sec id="Sec15"><title><offsets xml_i="31652" xml_f="31665" txt_i="17508" txt_f="17521">Data analyses</offsets></title><p><offsets xml_i="31676" xml_f="31774" txt_i="17522" txt_f="17620">Differences between groups are tested with relevant statistical models, e.g., independent samples </offsets><italic><offsets xml_i="31782" xml_f="31783" txt_i="17620" txt_f="17621">t</offsets></italic></p></sec><sec id="Sec16"><title><offsets xml_i="31825" xml_f="31836" txt_i="17623" txt_f="17634">Sample size</offsets></title><p><offsets xml_i="31847" xml_f="32239" txt_i="17635" txt_f="18027">On the basis of sample size calculation for both of the primary outcomes, 400 + 400 study subjects, allowing for a 20% drop-out rate, a 0.2 SD difference can be detected with p at 0.05 and ß of 0.9. In bone mineral content, a 0.2 SD increase requires 210 + 210 subjects, and a similar increase in bone cross sectional area 297 + 297 subjects as measured by the same technique as here (pQCT) [</offsets><xref ref-type="bibr" rid="CR63"><offsets xml_i="32272" xml_f="32274" txt_i="18027" txt_f="18029">63</offsets></xref><offsets xml_i="32281" xml_f="32364" txt_i="18029" txt_f="18112">]. The annual rate of infections in children below 2 years of age is 6 (SD ± 1.6) [</offsets><xref ref-type="bibr" rid="CR64"><offsets xml_i="32397" xml_f="32399" txt_i="18112" txt_f="18114">64</offsets></xref><offsets xml_i="32406" xml_f="32408" txt_i="18114" txt_f="18116">, </offsets><xref ref-type="bibr" rid="CR65"><offsets xml_i="32441" xml_f="32443" txt_i="18116" txt_f="18118">65</offsets></xref><offsets xml_i="32450" xml_f="32642" txt_i="18118" txt_f="18310">]. In the group receiving 30 μg of vitamin D we expect a decrease from 12 to 9 infections during the 24-month study period. A sample size of 220 + 220 is required to achieve statistical power.</offsets></p></sec></sec><sec id="Sec17" sec-type="discussion"><title><offsets xml_i="32703" xml_f="32713" txt_i="18313" txt_f="18323">Discussion</offsets></title><p><offsets xml_i="32724" xml_f="33344" txt_i="18324" txt_f="18944">To the best of our knowledge, this is the largest and most comprehensive randomised intervention study to assess the effects of vitamin D supplementation on skeletal and extra skeletal outcomes in infants. To date, epidemiological studies and randomised intervention trials have demonstrated conflicting results on, for example, the effect of vitamin D supplementation on childhood infections and on neurocognitive functioning. This may be due to difficulties in addressing the multiple confounding factors affecting the association between exposure and outcome. The present study, based on findings from a pilot study [</offsets><xref ref-type="bibr" rid="CR62"><offsets xml_i="33377" xml_f="33379" txt_i="18944" txt_f="18946">62</offsets></xref><offsets xml_i="33386" xml_f="33945" txt_i="18946" txt_f="19505">], is designated to specific hypothesis with adequate statistical power and duration. During the study, we gather data on infant diet at home and day care, psychological profiles and atopy-related symptoms using questionnaires. Results from this study will likely generate novel evidence-based information for improving vitamin D status among the paediatric population worldwide. By analysis of the impact of gene polymorphisms on the concentration and efficacy of the given vitamin D substitution it may create the basis for individualised dosage guidelines.</offsets></p><sec id="Sec18"><title><offsets xml_i="33972" xml_f="33996" txt_i="19506" txt_f="19530">Limitations of the study</offsets></title><p><offsets xml_i="34007" xml_f="34303" txt_i="19531" txt_f="19827">Compliance of the study subjects is always an issue in intervention trials. We are collecting used vitamin D bottles to evaluate the amount of vitamin D left after each cycle. These data, and parentally kept diaries on the use of vitamin D are used to evaluate the compliance in vitamin D intake.</offsets></p><p><offsets xml_i="34310" xml_f="34501" txt_i="19828" txt_f="20019">Questionnaires may be improperly filled, resulting in missing data on, for example, parent-reported infections. Therefore, national registers can be used for the validation of caregiver data.</offsets></p><p><offsets xml_i="34508" xml_f="34887" txt_i="20020" txt_f="20399">The results from a study performed in Finland cannot be directly generalised to other parts of the world. However, due to the randomised controlled study design our study will provide valuable data on the effects of vitamin D substitution in populations with variable vitamin D status. In addition, the study is designed to have control over the most common sources of vitamin D.</offsets></p><p><offsets xml_i="34894" xml_f="35219" txt_i="20400" txt_f="20725">If the results from the VIDI-trial confirm the connections between the increased dose of vitamin D and the primary outcomes, the health benefits gained by a population-wide supplementation with higher vitamin D dose — a simple and low-cost intervention — are obvious. The first results of the VIDI-trial are expected in 2017.</offsets></p></sec></sec></body><back><app-group><app id="App1"><sec id="Sec19"><title>Additional file</title><p>
<media position="anchor" xlink:href="12887_2017_845_MOESM1_ESM.docx" id="MOESM1"><label>Additional file 1:</label><caption><p>Supplementary documentation. Methods described in further detail. (DOCX 520 kb)</p></caption></media>
</p></sec></app></app-group><glossary><title>Abbreviations</title><def-list><def-item><term>25-OHD</term><def><p>25-hydroxy-vitamin D</p></def></def-item><def-item><term>BMD</term><def><p>Bone mineral density</p></def></def-item><def-item><term>DBP</term><def><p>Vitamin D binding protein</p></def></def-item><def-item><term>S-25-OHD</term><def><p>serum 25-OHD</p></def></def-item><def-item><term>VDR</term><def><p>Vitamin D receptor</p></def></def-item></def-list></glossary><ack><title>Acknowledgements</title><p>We are grateful to all the families participating in the study. Also, we are grateful to the research nurses Sirpa Nolvi, Rhea Paajanen, Nea Boman, and Päivi Turunen for their assistance in data collection. Laboratory technician Sari Linden is acknowledged for her valuable contribution.</p><sec id="FPar1"><title>Funding</title><p>This study is being funded by the Governmental Subsidy for Clinical Research, Foundation for Pediatric Research, Finska Läkaresällskapet, Folkhälsan Research Foundation, Sigrid Juselius Foundation, Emil Aaltonen Foundation, Stiftelsen Dorothea Olivia, Karl Walter ooh Jarl Walter Perkléns minne, and Päivikki and Sakari Sohlberg Foundation.</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p>Data from the study are made publicly available in the main papers published from the study, or in their Additional file <xref rid="MOESM1" ref-type="media">1</xref>.</p></sec><sec id="FPar3"><title>Authors’ contributions</title><p>The authors’ contributions are as follows: OH, HV, EH-S, KH, KR, TH, OM and SA designed the study; OH, HV, EH-S, JR, HH, SV, ME-C and TH conducted the research; OH, HV, KH, KR, OM and SA wrote the first draft of the manuscript; OH had primary responsibility for final content; all authors critically reviewed the manuscript. All of the authors read and approved the final version.</p></sec><sec id="FPar4"><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec id="FPar5"><title>Consent for publication</title><p>Not applicable.</p></sec><sec id="FPar6"><title>Ethics approval and consent to participate</title><p>The Research Ethics Committee of the Hospital District of Helsinki and Uusimaa has approved the study (ID 107/13/03/03/2012) and it is registered into ClinicalTrials.com (<ext-link ext-link-type="uri" xlink:href="http://www.clinicaltrials.gov/NCT01723852">NCT01723852</ext-link>). An informed consent was obtained from the parents at recruitment.</p></sec><sec id="FPar7"><title>Publisher’s Note</title><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christakos</surname><given-names>S</given-names></name><name><surname>Dhawan</surname><given-names>P</given-names></name><name><surname>Verstuyf</surname><given-names>A</given-names></name><name><surname>Verlinden</surname><given-names>L</given-names></name><name><surname>Carmeliet</surname><given-names>G</given-names></name></person-group><article-title>Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects</article-title><source>Physiol Rev</source><year>2016</year><volume>96</volume><issue>1</issue><fpage>365</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1152/physrev.00014.2015</pub-id><pub-id pub-id-type="pmid">26681795</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mora</surname><given-names>JR</given-names></name><name><surname>Iwata</surname><given-names>M</given-names></name><name><surname>von Andrian</surname><given-names>UH</given-names></name></person-group><article-title>Vitamin effects on the immune system: vitamins A and D take centre stage</article-title><source>Nat Rev Immunol</source><year>2008</year><volume>8</volume><issue>9</issue><fpage>685</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1038/nri2378</pub-id><pub-id pub-id-type="pmid">19172691</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norman</surname><given-names>AW</given-names></name></person-group><article-title>From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health</article-title><source>Am J Clin Nutr</source><year>2008</year><volume>88</volume><issue>2</issue><fpage>491S</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">18689389</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouillon</surname><given-names>R</given-names></name><name><surname>Bischoff-Ferrari</surname><given-names>H</given-names></name><name><surname>Willett</surname><given-names>W</given-names></name></person-group><article-title>Vitamin D and health: perspectives from mice and man</article-title><source>J Bone Miner Res</source><year>2008</year><volume>23</volume><issue>7</issue><fpage>974</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1359/jbmr.080420</pub-id><pub-id pub-id-type="pmid">18442312</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hewison</surname><given-names>M</given-names></name></person-group><article-title>An update on vitamin D and human immunity</article-title><source>Clin Endocrinol</source><year>2012</year><volume>76</volume><issue>3</issue><fpage>315</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2265.2011.04261.x</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>AC</given-names></name></person-group><article-title>The 2011 report on dietary reference intakes for calcium and vitamin D</article-title><source>Public Health Nutr</source><year>2011</year><volume>14</volume><issue>5</issue><fpage>938</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1017/S1368980011000565</pub-id><pub-id pub-id-type="pmid">21492489</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holick</surname><given-names>MF</given-names></name><name><surname>Binkley</surname><given-names>NC</given-names></name><name><surname>Bischoff-Ferrari</surname><given-names>HA</given-names></name><name><surname>Gordon</surname><given-names>CM</given-names></name><name><surname>Hanley</surname><given-names>DA</given-names></name><name><surname>Heaney</surname><given-names>RP</given-names></name><name><surname>Murad</surname><given-names>MH</given-names></name><name><surname>Weaver</surname><given-names>CM</given-names></name></person-group><article-title>Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited</article-title><source>J Clin Endocrinol Metab</source><year>2012</year><volume>97</volume><issue>4</issue><fpage>1153</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1210/jc.2011-2601</pub-id><pub-id pub-id-type="pmid">22442274</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viljakainen</surname><given-names>HT</given-names></name><name><surname>Korhonen</surname><given-names>T</given-names></name><name><surname>Hytinantti</surname><given-names>T</given-names></name><name><surname>Laitinen</surname><given-names>EK</given-names></name><name><surname>Andersson</surname><given-names>S</given-names></name><name><surname>Makitie</surname><given-names>O</given-names></name><name><surname>Lamberg-Allardt</surname><given-names>C</given-names></name></person-group><article-title>Maternal vitamin D status affects bone growth in early childhood--a prospective cohort study</article-title><source>Osteoporosis Int</source><year>2011</year><volume>22</volume><issue>3</issue><fpage>883</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1007/s00198-010-1499-4</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pekkinen</surname><given-names>M</given-names></name><name><surname>Viljakainen</surname><given-names>H</given-names></name><name><surname>Saarnio</surname><given-names>E</given-names></name><name><surname>Lamberg-Allardt</surname><given-names>C</given-names></name><name><surname>Makitie</surname><given-names>O</given-names></name></person-group><article-title>Vitamin D is a major determinant of bone mineral density at school age</article-title><source>PloS one</source><year>2012</year><volume>7</volume><issue>7</issue><fpage>e40090</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0040090</pub-id><pub-id pub-id-type="pmid">22768331</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="other">Soininen S, Eloranta AM, Lindi V, Venalainen T, Zaproudina N, Mahonen A, Lakka TA: Determinants of serum 25-hydroxyvitamin D concentration in Finnish children: the Physical Activity and Nutrition in Children (PANIC) study. Br J Nutr. 2016;115(6):1080–91.</mixed-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elder</surname><given-names>CJ</given-names></name><name><surname>Bishop</surname><given-names>NJ</given-names></name></person-group><article-title>Rickets</article-title><source>Lancet</source><year>2014</year><volume>383</volume><issue>9929</issue><fpage>1665</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(13)61650-5</pub-id><pub-id pub-id-type="pmid">24412049</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viljakainen</surname><given-names>HT</given-names></name><name><surname>Saarnio</surname><given-names>E</given-names></name><name><surname>Hytinantti</surname><given-names>T</given-names></name><name><surname>Miettinen</surname><given-names>M</given-names></name><name><surname>Surcel</surname><given-names>H</given-names></name><name><surname>Makitie</surname><given-names>O</given-names></name><name><surname>Andersson</surname><given-names>S</given-names></name><name><surname>Laitinen</surname><given-names>K</given-names></name><name><surname>Lamberg-Allardt</surname><given-names>C</given-names></name></person-group><article-title>Maternal vitamin D status determines bone variables in the newborn</article-title><source>J Clin Endocrinol Metab</source><year>2010</year><volume>95</volume><issue>4</issue><fpage>1749</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1210/jc.2009-1391</pub-id><pub-id pub-id-type="pmid">20139235</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayranpaa</surname><given-names>MK</given-names></name><name><surname>Tamminen</surname><given-names>IS</given-names></name><name><surname>Kroger</surname><given-names>H</given-names></name><name><surname>Makitie</surname><given-names>O</given-names></name></person-group><article-title>Bone biopsy findings and correlation with clinical, radiological, and biochemical parameters in children with fractures</article-title><source>J Bone Miner Res</source><year>2011</year><volume>26</volume><issue>8</issue><fpage>1748</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1002/jbmr.373</pub-id><pub-id pub-id-type="pmid">21351145</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winzenberg</surname><given-names>T</given-names></name><name><surname>Powell</surname><given-names>S</given-names></name><name><surname>Shaw</surname><given-names>KA</given-names></name><name><surname>Jones</surname><given-names>G</given-names></name></person-group><article-title>Effects of vitamin D supplementation on bone density in healthy children: systematic review and meta-analysis</article-title><source>BMJ</source><year>2011</year><volume>342</volume><fpage>c7254</fpage><pub-id pub-id-type="doi">10.1136/bmj.c7254</pub-id><pub-id pub-id-type="pmid">21266418</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cranney</surname><given-names>A</given-names></name><name><surname>Weiler</surname><given-names>HA</given-names></name><name><surname>O'Donnell</surname><given-names>S</given-names></name><name><surname>Puil</surname><given-names>L</given-names></name></person-group><article-title>Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health</article-title><source>Am J Clin Nutr</source><year>2008</year><volume>88</volume><issue>2</issue><fpage>513S</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">18689393</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettifor</surname><given-names>JM</given-names></name><name><surname>Prentice</surname><given-names>A</given-names></name></person-group><article-title>The role of vitamin D in paediatric bone health</article-title><source>Best Pract Res Clin Endocrinol Metab</source><year>2011</year><volume>25</volume><issue>4</issue><fpage>573</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/j.beem.2011.06.010</pub-id><pub-id pub-id-type="pmid">21872799</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soliman</surname><given-names>A</given-names></name><name><surname>Salama</surname><given-names>H</given-names></name><name><surname>Alomar</surname><given-names>S</given-names></name><name><surname>Shatla</surname><given-names>E</given-names></name><name><surname>Ellithy</surname><given-names>K</given-names></name><name><surname>Bedair</surname><given-names>E</given-names></name></person-group><article-title>Clinical, biochemical, and radiological manifestations of vitamin D deficiency in newborns presented with hypocalcemia</article-title><source>Indian J Endocrinol Metab</source><year>2013</year><volume>17</volume><issue>4</issue><fpage>697</fpage><lpage>703</lpage><pub-id pub-id-type="doi">10.4103/2230-8210.113764</pub-id><pub-id pub-id-type="pmid">23961489</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soliman</surname><given-names>AT</given-names></name><name><surname>El-Dabbagh</surname><given-names>M</given-names></name><name><surname>Adel</surname><given-names>A</given-names></name><name><surname>Al Ali</surname><given-names>M</given-names></name><name><surname>Aziz Bedair</surname><given-names>EM</given-names></name><name><surname>Elalaily</surname><given-names>RK</given-names></name></person-group><article-title>Clinical responses to a mega-dose of vitamin D3 in infants and toddlers with vitamin D deficiency rickets</article-title><source>J Trop Pediatr</source><year>2010</year><volume>56</volume><issue>1</issue><fpage>19</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1093/tropej/fmp040</pub-id><pub-id pub-id-type="pmid">19506025</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>GT</given-names></name><name><surname>Sachdev</surname><given-names>HS</given-names></name><name><surname>Chellani</surname><given-names>H</given-names></name><name><surname>Rehman</surname><given-names>AM</given-names></name><name><surname>Singh</surname><given-names>V</given-names></name><name><surname>Arora</surname><given-names>H</given-names></name><name><surname>Filteau</surname><given-names>S</given-names></name></person-group><article-title>Effect of weekly vitamin D supplements on mortality, morbidity, and growth of low birthweight term infants in India up to age 6 months: randomised controlled trial</article-title><source>BMJ</source><year>2011</year><volume>342</volume><fpage>d2975</fpage><pub-id pub-id-type="doi">10.1136/bmj.d2975</pub-id><pub-id pub-id-type="pmid">21628364</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wayse</surname><given-names>V</given-names></name><name><surname>Yousafzai</surname><given-names>A</given-names></name><name><surname>Mogale</surname><given-names>K</given-names></name><name><surname>Filteau</surname><given-names>S</given-names></name></person-group><article-title>Association of subclinical vitamin D deficiency with severe acute lower respiratory infection in Indian children under 5 y</article-title><source>Eur J Clin Nutr</source><year>2004</year><volume>58</volume><issue>4</issue><fpage>563</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1038/sj.ejcn.1601845</pub-id><pub-id pub-id-type="pmid">15042122</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karatekin</surname><given-names>G</given-names></name><name><surname>Kaya</surname><given-names>A</given-names></name><name><surname>Salihoglu</surname><given-names>O</given-names></name><name><surname>Balci</surname><given-names>H</given-names></name><name><surname>Nuhoglu</surname><given-names>A</given-names></name></person-group><article-title>Association of subclinical vitamin D deficiency in newborns with acute lower respiratory infection and their mothers</article-title><source>Eur J Clin Nutr</source><year>2009</year><volume>63</volume><issue>4</issue><fpage>473</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1038/sj.ejcn.1602960</pub-id><pub-id pub-id-type="pmid">18030309</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holick</surname><given-names>MF</given-names></name></person-group><article-title>Vitamin D deficiency</article-title><source>N Engl J Med</source><year>2007</year><volume>357</volume><issue>3</issue><fpage>266</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1056/NEJMra070553</pub-id><pub-id pub-id-type="pmid">17634462</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Rosa</surname><given-names>M</given-names></name><name><surname>Malaguarnera</surname><given-names>M</given-names></name><name><surname>Nicoletti</surname><given-names>F</given-names></name><name><surname>Malaguarnera</surname><given-names>L</given-names></name></person-group><article-title>Vitamin D3: a helpful immuno-modulator</article-title><source>Immunology</source><year>2011</year><volume>134</volume><issue>2</issue><fpage>123</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2567.2011.03482.x</pub-id><pub-id pub-id-type="pmid">21896008</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khoo</surname><given-names>AL</given-names></name><name><surname>Chai</surname><given-names>L</given-names></name><name><surname>Koenen</surname><given-names>H</given-names></name><name><surname>Joosten</surname><given-names>I</given-names></name><name><surname>Netea</surname><given-names>M</given-names></name><name><surname>van der Ven</surname><given-names>A</given-names></name></person-group><article-title>Translating the role of vitamin D(3) in infectious diseases</article-title><source>Crit Rev Microbiol</source><year>2012</year><volume>38</volume><issue>2</issue><fpage>122</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.3109/1040841X.2011.622716</pub-id><pub-id pub-id-type="pmid">22304022</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinholz</surname><given-names>M</given-names></name><name><surname>Ruzicka</surname><given-names>T</given-names></name><name><surname>Schauber</surname><given-names>J</given-names></name></person-group><article-title>Vitamin D and its role in allergic disease</article-title><source>Clin Exp Allergy</source><year>2012</year><volume>42</volume><issue>6</issue><fpage>817</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">22192170</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiosano</surname><given-names>D</given-names></name><name><surname>Wildbaum</surname><given-names>G</given-names></name><name><surname>Gepstein</surname><given-names>V</given-names></name><name><surname>Verbitsky</surname><given-names>O</given-names></name><name><surname>Weisman</surname><given-names>Y</given-names></name><name><surname>Karin</surname><given-names>N</given-names></name><name><surname>Eztioni</surname><given-names>A</given-names></name></person-group><article-title>The role of vitamin D receptor in innate and adaptive immunity: a study in hereditary vitamin D-resistant rickets patients</article-title><source>J Clin Endocrinol Metab</source><year>2013</year><volume>98</volume><issue>4</issue><fpage>1685</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1210/jc.2012-3858</pub-id><pub-id pub-id-type="pmid">23482605</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hewison</surname><given-names>M</given-names></name></person-group><article-title>Antibacterial effects of vitamin D</article-title><source>Nat Rev Endocrinol</source><year>2011</year><volume>7</volume><issue>6</issue><fpage>337</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1038/nrendo.2010.226</pub-id><pub-id pub-id-type="pmid">21263449</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ginde</surname><given-names>AA</given-names></name><name><surname>Camargo</surname><given-names>CA</given-names><suffix>Jr</suffix></name><name><surname>Shapiro</surname><given-names>NI</given-names></name></person-group><article-title>Vitamin D insufficiency and sepsis severity in emergency department patients with suspected infection</article-title><source>Acad Emerg Med</source><year>2011</year><volume>18</volume><issue>5</issue><fpage>551</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1111/j.1553-2712.2011.01047.x</pub-id><pub-id pub-id-type="pmid">21518095</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gradel</surname><given-names>L</given-names></name><name><surname>Merker</surname><given-names>M</given-names></name><name><surname>Mueller</surname><given-names>B</given-names></name><name><surname>Schuetz</surname><given-names>P</given-names></name></person-group><article-title>Screening and treatment of vitamin D deficiency in the emergency department - is there a benefit for medical inpatients?</article-title><source>Am J Med</source><year>2015</year><volume>129</volume><issue>1</issue><fpage>116e1</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.amjmed.2015.06.034</pub-id><pub-id pub-id-type="pmid">26169890</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNally</surname><given-names>JD</given-names></name><name><surname>Leis</surname><given-names>K</given-names></name><name><surname>Matheson</surname><given-names>LA</given-names></name><name><surname>Karuananyake</surname><given-names>C</given-names></name><name><surname>Sankaran</surname><given-names>K</given-names></name><name><surname>Rosenberg</surname><given-names>AM</given-names></name></person-group><article-title>Vitamin D deficiency in young children with severe acute lower respiratory infection</article-title><source>Ped Pulm</source><year>2009</year><volume>44</volume><issue>10</issue><fpage>981</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1002/ppul.21089</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urashima</surname><given-names>M</given-names></name><name><surname>Segawa</surname><given-names>T</given-names></name><name><surname>Okazaki</surname><given-names>M</given-names></name><name><surname>Kurihara</surname><given-names>M</given-names></name><name><surname>Wada</surname><given-names>Y</given-names></name><name><surname>Ida</surname><given-names>H</given-names></name></person-group><article-title>Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren</article-title><source>Am J Clin Nutr</source><year>2010</year><volume>91</volume><issue>5</issue><fpage>1255</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.3945/ajcn.2009.29094</pub-id><pub-id pub-id-type="pmid">20219962</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Science</surname><given-names>M</given-names></name><name><surname>Maguire</surname><given-names>JL</given-names></name><name><surname>Russell</surname><given-names>ML</given-names></name><name><surname>Smieja</surname><given-names>M</given-names></name><name><surname>Walter</surname><given-names>SD</given-names></name><name><surname>Loeb</surname><given-names>M</given-names></name></person-group><article-title>Low serum 25-hydroxyvitamin D level and risk of upper respiratory tract infection in children and adolescents</article-title><source>Clin Infect Dis</source><year>2013</year><volume>57</volume><issue>3</issue><fpage>392</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1093/cid/cit289</pub-id><pub-id pub-id-type="pmid">23677871</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thornton</surname><given-names>KA</given-names></name><name><surname>Marin</surname><given-names>C</given-names></name><name><surname>Mora-Plazas</surname><given-names>M</given-names></name><name><surname>Villamor</surname><given-names>E</given-names></name></person-group><article-title>Vitamin D deficiency associated with increased incidence of gastrointestinal and ear infections in school-age children</article-title><source>Pediatr Infect Dis J</source><year>2013</year><volume>32</volume><issue>6</issue><fpage>585</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1097/INF.0b013e3182868989</pub-id><pub-id pub-id-type="pmid">23340562</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hugg</surname><given-names>T</given-names></name><name><surname>Ruotsalainen</surname><given-names>R</given-names></name><name><surname>Jaakkola</surname><given-names>MS</given-names></name><name><surname>Pushkarev</surname><given-names>V</given-names></name><name><surname>Jaakkola</surname><given-names>JJ</given-names></name></person-group><article-title></article-title><source>Eur J Epidemiol</source><year>2008</year><volume>23</volume><issue>2</issue><fpage>123</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1007/s10654-007-9217-z</pub-id><pub-id pub-id-type="pmid">18202828</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erkkola</surname><given-names>M</given-names></name><name><surname>Kaila</surname><given-names>M</given-names></name><name><surname>Nwaru</surname><given-names>BI</given-names></name><name><surname>Kronberg-Kippila</surname><given-names>C</given-names></name><name><surname>Ahonen</surname><given-names>S</given-names></name><name><surname>Nevalainen</surname><given-names>J</given-names></name><name><surname>Veijola</surname><given-names>R</given-names></name><name><surname>Pekkanen</surname><given-names>J</given-names></name><name><surname>Ilonen</surname><given-names>J</given-names></name><name><surname>Simell</surname><given-names>O</given-names></name><etal></etal></person-group><article-title>Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children</article-title><source>Clin Exp Allergy</source><year>2009</year><volume>39</volume><issue>6</issue><fpage>875</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2222.2009.03234.x</pub-id><pub-id pub-id-type="pmid">19522996</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Arguelles</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Tsai</surname><given-names>HJ</given-names></name><name><surname>Hong</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>R</given-names></name><name><surname>Price</surname><given-names>HE</given-names></name><name><surname>Pearson</surname><given-names>C</given-names></name><etal></etal></person-group><article-title>Longitudinal trajectory of vitamin D status from birth to early childhood in the development of food sensitization</article-title><source>Pediatr Res</source><year>2013</year><volume>74</volume><issue>3</issue><fpage>321</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1038/pr.2013.110</pub-id><pub-id pub-id-type="pmid">23797532</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baiz</surname><given-names>N</given-names></name><name><surname>Dargent-Molina</surname><given-names>P</given-names></name><name><surname>Wark</surname><given-names>JD</given-names></name><name><surname>Souberbielle</surname><given-names>JC</given-names></name><name><surname>Annesi-Maesano</surname><given-names>I</given-names></name><collab>EM-CCS Group</collab></person-group><article-title>Cord serum 25-hydroxyvitamin D and risk of early childhood transient wheezing and atopic dermatitis</article-title><source>J Allergy Clin Immunol</source><year>2014</year><volume>133</volume><issue>1</issue><fpage>147</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2013.05.017</pub-id><pub-id pub-id-type="pmid">23810764</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname><given-names>CY</given-names></name><name><surname>Yao</surname><given-names>TC</given-names></name><name><surname>Chen</surname><given-names>SH</given-names></name><name><surname>Tsai</surname><given-names>MH</given-names></name><name><surname>Tu</surname><given-names>YL</given-names></name><name><surname>Hua</surname><given-names>MC</given-names></name><name><surname>Yeh</surname><given-names>KW</given-names></name><name><surname>Huang</surname><given-names>JL</given-names></name></person-group><article-title>Low cord blood vitamin D levels are associated with increased milk sensitization in early childhood</article-title><source>Pediatr Allergy Immunol</source><year>2014</year><volume>25</volume><issue>8</issue><fpage>767</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1111/pai.12304</pub-id><pub-id pub-id-type="pmid">25389018</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>AP</given-names></name><name><surname>Palmer</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Prescott</surname><given-names>SL</given-names></name></person-group><article-title>Cord blood 25-hydroxyvitamin D3 and allergic disease during infancy</article-title><source>Pediatrics</source><year>2012</year><volume>130</volume><issue>5</issue><fpage>e1128</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1542/peds.2012-1172</pub-id><pub-id pub-id-type="pmid">23090338</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chawes</surname><given-names>BL</given-names></name><name><surname>Bonnelykke</surname><given-names>K</given-names></name><name><surname>Stokholm</surname><given-names>J</given-names></name><name><surname>Vissing</surname><given-names>NH</given-names></name><name><surname>Bjarnadottir</surname><given-names>E</given-names></name><name><surname>Schoos</surname><given-names>AM</given-names></name><name><surname>Wolsk</surname><given-names>HM</given-names></name><name><surname>Pedersen</surname><given-names>TM</given-names></name><name><surname>Vinding</surname><given-names>RK</given-names></name><name><surname>Thorsteinsdottir</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>Effect of vitamin D3 supplementation during pregnancy on risk of persistent wheeze in the offspring: a randomized clinical trial</article-title><source>JAMA</source><year>2016</year><volume>315</volume><issue>4</issue><fpage>353</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1001/jama.2015.18318</pub-id><pub-id pub-id-type="pmid">26813208</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Litonjua</surname><given-names>AA</given-names></name><name><surname>Carey</surname><given-names>VJ</given-names></name><name><surname>Laranjo</surname><given-names>N</given-names></name><name><surname>Harshfield</surname><given-names>BJ</given-names></name><name><surname>McElrath</surname><given-names>TF</given-names></name><name><surname>O'Connor</surname><given-names>GT</given-names></name><name><surname>Sandel</surname><given-names>M</given-names></name><name><surname>Iverson</surname><given-names>RE</given-names><suffix>Jr</suffix></name><name><surname>Lee-Paritz</surname><given-names>A</given-names></name><name><surname>Strunk</surname><given-names>RC</given-names></name><etal></etal></person-group><article-title>Effect of prenatal supplementation with vitamin D on asthma or recurrent wheezing in offspring by age 3 years: the VDAART randomized clinical trial</article-title><source>JAMA</source><year>2016</year><volume>315</volume><issue>4</issue><fpage>362</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1001/jama.2015.18589</pub-id><pub-id pub-id-type="pmid">26813209</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riverin</surname><given-names>BD</given-names></name><name><surname>Maguire</surname><given-names>JL</given-names></name><name><surname>Li</surname><given-names>P</given-names></name></person-group><article-title>Vitamin D supplementation for childhood asthma: a systematic review and meta-analysis</article-title><source>PloS one</source><year>2015</year><volume>10</volume><issue>8</issue><fpage>e0136841</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0136841</pub-id><pub-id pub-id-type="pmid">26322509</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hypponen</surname><given-names>E</given-names></name><name><surname>Berry</surname><given-names>DJ</given-names></name><name><surname>Wjst</surname><given-names>M</given-names></name><name><surname>Power</surname><given-names>C</given-names></name></person-group><article-title>Serum 25-hydroxyvitamin D and IgE - a significant but nonlinear relationship</article-title><source>Allergy</source><year>2009</year><volume>64</volume><issue>4</issue><fpage>613</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1111/j.1398-9995.2008.01865.x</pub-id><pub-id pub-id-type="pmid">19154546</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balion</surname><given-names>C</given-names></name><name><surname>Griffith</surname><given-names>LE</given-names></name><name><surname>Strifler</surname><given-names>L</given-names></name><name><surname>Henderson</surname><given-names>M</given-names></name><name><surname>Patterson</surname><given-names>C</given-names></name><name><surname>Heckman</surname><given-names>G</given-names></name><name><surname>Llewellyn</surname><given-names>DJ</given-names></name><name><surname>Raina</surname><given-names>P</given-names></name></person-group><article-title>Vitamin D, cognition, and dementia: a systematic review and meta-analysis</article-title><source>Neurology</source><year>2012</year><volume>79</volume><issue>13</issue><fpage>1397</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1212/WNL.0b013e31826c197f</pub-id><pub-id pub-id-type="pmid">23008220</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etgen</surname><given-names>T</given-names></name><name><surname>Sander</surname><given-names>D</given-names></name><name><surname>Bickel</surname><given-names>H</given-names></name><name><surname>Sander</surname><given-names>K</given-names></name><name><surname>Forstl</surname><given-names>H</given-names></name></person-group><article-title>Vitamin D deficiency, cognitive impairment and dementia: a systematic review and meta-analysis</article-title><source>Dement Geriatr Cogn Disord</source><year>2012</year><volume>33</volume><issue>5</issue><fpage>297</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1159/000339702</pub-id><pub-id pub-id-type="pmid">22759681</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Annweiler</surname><given-names>C</given-names></name><name><surname>Montero-Odasso</surname><given-names>M</given-names></name><name><surname>Llewellyn</surname><given-names>DJ</given-names></name><name><surname>Richard-Devantoy</surname><given-names>S</given-names></name><name><surname>Duque</surname><given-names>G</given-names></name><name><surname>Beauchet</surname><given-names>O</given-names></name></person-group><article-title>Meta-analysis of memory and executive dysfunctions in relation to vitamin D</article-title><source>J Alzheimers Dis</source><year>2013</year><volume>37</volume><issue>1</issue><fpage>147</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">23948884</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dean</surname><given-names>AJ</given-names></name><name><surname>Bellgrove</surname><given-names>MA</given-names></name><name><surname>Hall</surname><given-names>T</given-names></name><name><surname>Phan</surname><given-names>WM</given-names></name><name><surname>Eyles</surname><given-names>DW</given-names></name><name><surname>Kvaskoff</surname><given-names>D</given-names></name><name><surname>McGrath</surname><given-names>JJ</given-names></name></person-group><article-title>Effects of vitamin D supplementation on cognitive and emotional functioning in young adults--a randomised controlled trial</article-title><source>PloS one</source><year>2011</year><volume>6</volume><issue>11</issue><fpage>e25966</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0025966</pub-id><pub-id pub-id-type="pmid">22073146</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossom</surname><given-names>RC</given-names></name><name><surname>Espeland</surname><given-names>MA</given-names></name><name><surname>Manson</surname><given-names>JE</given-names></name><name><surname>Dysken</surname><given-names>MW</given-names></name><name><surname>Johnson</surname><given-names>KC</given-names></name><name><surname>Lane</surname><given-names>DS</given-names></name><name><surname>LeBlanc</surname><given-names>ES</given-names></name><name><surname>Lederle</surname><given-names>FA</given-names></name><name><surname>Masaki</surname><given-names>KH</given-names></name><name><surname>Margolis</surname><given-names>KL</given-names></name></person-group><article-title>Calcium and vitamin D supplementation and cognitive impairment in the women’s health initiative</article-title><source>J Am Geriatr Soc</source><year>2012</year><volume>60</volume><issue>12</issue><fpage>2197</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1111/jgs.12032</pub-id><pub-id pub-id-type="pmid">23176129</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>P</given-names></name><name><surname>Tong</surname><given-names>SL</given-names></name><name><surname>Hao</surname><given-names>JH</given-names></name><name><surname>Tao</surname><given-names>RX</given-names></name><name><surname>Huang</surname><given-names>K</given-names></name><name><surname>Hu</surname><given-names>WB</given-names></name><name><surname>Zhou</surname><given-names>QF</given-names></name><name><surname>Jiang</surname><given-names>XM</given-names></name><name><surname>Tao</surname><given-names>FB</given-names></name></person-group><article-title>Cord blood vitamin D and neurocognitive development are nonlinearly related in toddlers</article-title><source>J Nutr</source><year>2015</year><volume>145</volume><issue>6</issue><fpage>1232</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.3945/jn.114.208801</pub-id><pub-id pub-id-type="pmid">25878203</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGrath</surname><given-names>J</given-names></name><name><surname>Scragg</surname><given-names>R</given-names></name><name><surname>Chant</surname><given-names>D</given-names></name><name><surname>Eyles</surname><given-names>D</given-names></name><name><surname>Burne</surname><given-names>T</given-names></name><name><surname>Obradovic</surname><given-names>D</given-names></name></person-group><article-title>No association between serum 25-hydroxyvitamin D3 level and performance on psychometric tests in NHANES III</article-title><source>Neuroepidemiology</source><year>2007</year><volume>29</volume><issue>1–2</issue><fpage>49</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1159/000108918</pub-id><pub-id pub-id-type="pmid">17898524</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tolppanen</surname><given-names>AM</given-names></name><name><surname>Williams</surname><given-names>D</given-names></name><name><surname>Lawlor</surname><given-names>DA</given-names></name></person-group><article-title>The association of circulating 25-hydroxyvitamin D and calcium with cognitive performance in adolescents: cross-sectional study using data from the third National Health and Nutrition Examination Survey</article-title><source>Paediatr Perinat Epidemiol</source><year>2011</year><volume>25</volume><issue>1</issue><fpage>67</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1111/j.1365-3016.2010.01171.x</pub-id><pub-id pub-id-type="pmid">21133971</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tolppanen</surname><given-names>AM</given-names></name><name><surname>Sayers</surname><given-names>A</given-names></name><name><surname>Fraser</surname><given-names>WD</given-names></name><name><surname>Lawlor</surname><given-names>DA</given-names></name></person-group><article-title>Association of serum 25-hydroxyvitamin D(3) and D(2) with academic performance in childhood: findings from a prospective birth cohort</article-title><source>J Epidemiol Community Health</source><year>2012</year><volume>66</volume><issue>12</issue><fpage>1137</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1136/jech-2011-200114</pub-id><pub-id pub-id-type="pmid">22493513</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nissen</surname><given-names>J</given-names></name><name><surname>Rasmussen</surname><given-names>LB</given-names></name><name><surname>Ravn-Haren</surname><given-names>G</given-names></name><name><surname>Andersen</surname><given-names>EW</given-names></name><name><surname>Hansen</surname><given-names>B</given-names></name><name><surname>Andersen</surname><given-names>R</given-names></name><name><surname>Mejborn</surname><given-names>H</given-names></name><name><surname>Madsen</surname><given-names>KH</given-names></name><name><surname>Vogel</surname><given-names>U</given-names></name></person-group><article-title>Common variants in CYP2R1 and GC genes predict vitamin D concentrations in healthy Danish children and adults</article-title><source>PloS one</source><year>2014</year><volume>9</volume><issue>2</issue><fpage>e89907</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0089907</pub-id><pub-id pub-id-type="pmid">24587115</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>TJ</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Richards</surname><given-names>JB</given-names></name><name><surname>Kestenbaum</surname><given-names>B</given-names></name><name><surname>van Meurs</surname><given-names>JB</given-names></name><name><surname>Berry</surname><given-names>D</given-names></name><name><surname>Kiel</surname><given-names>DP</given-names></name><name><surname>Streeten</surname><given-names>EA</given-names></name><name><surname>Ohlsson</surname><given-names>C</given-names></name><name><surname>Koller</surname><given-names>DL</given-names></name><etal></etal></person-group><article-title>Common genetic determinants of vitamin D insufficiency: a genome-wide association study</article-title><source>Lancet</source><year>2010</year><volume>376</volume><issue>9736</issue><fpage>180</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(10)60588-0</pub-id><pub-id pub-id-type="pmid">20541252</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pekkinen</surname><given-names>M</given-names></name><name><surname>Saarnio</surname><given-names>E</given-names></name><name><surname>Viljakainen</surname><given-names>HT</given-names></name><name><surname>Kokkonen</surname><given-names>E</given-names></name><name><surname>Jakobsen</surname><given-names>J</given-names></name><name><surname>Cashman</surname><given-names>K</given-names></name><name><surname>Makitie</surname><given-names>O</given-names></name><name><surname>Lamberg-Allardt</surname><given-names>C</given-names></name></person-group><article-title>Vitamin D binding protein genotype is associated with serum 25-hydroxyvitamin D and PTH concentrations, as well as bone health in children and adolescents in Finland</article-title><source>PloS one</source><year>2014</year><volume>9</volume><issue>1</issue><fpage>e87292</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0087292</pub-id><pub-id pub-id-type="pmid">24498064</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morley</surname><given-names>R</given-names></name><name><surname>Carlin</surname><given-names>JB</given-names></name><name><surname>Pasco</surname><given-names>JA</given-names></name><name><surname>Wark</surname><given-names>JD</given-names></name><name><surname>Ponsonby</surname><given-names>AL</given-names></name></person-group><article-title>Maternal 25-hydroxyvitamin D concentration and offspring birth size: effect modification by infant VDR genotype</article-title><source>Eur J Clin Nutr</source><year>2009</year><volume>63</volume><issue>6</issue><fpage>802</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1038/ejcn.2008.55</pub-id><pub-id pub-id-type="pmid">19018272</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bodnar</surname><given-names>LM</given-names></name><name><surname>Catov</surname><given-names>JM</given-names></name><name><surname>Zmuda</surname><given-names>JM</given-names></name><name><surname>Cooper</surname><given-names>ME</given-names></name><name><surname>Parrott</surname><given-names>MS</given-names></name><name><surname>Roberts</surname><given-names>JM</given-names></name><name><surname>Marazita</surname><given-names>ML</given-names></name><name><surname>Simhan</surname><given-names>HN</given-names></name></person-group><article-title>Maternal serum 25-hydroxyvitamin D concentrations are associated with small-for-gestational age births in white women</article-title><source>J Nutr</source><year>2010</year><volume>140</volume><issue>5</issue><fpage>999</fpage><lpage>1006</lpage><pub-id pub-id-type="doi">10.3945/jn.109.119636</pub-id><pub-id pub-id-type="pmid">20200114</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>Y</given-names></name><name><surname>van Meurs</surname><given-names>JB</given-names></name><name><surname>Rivadeneira</surname><given-names>F</given-names></name><name><surname>van Schoor</surname><given-names>NM</given-names></name><name><surname>van Leeuwen</surname><given-names>JP</given-names></name><name><surname>Lips</surname><given-names>P</given-names></name><name><surname>Pols</surname><given-names>HA</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name></person-group><article-title>Vitamin D receptor gene haplotype is associated with body height and bone size</article-title><source>J Clin Endocrinol Metab</source><year>2007</year><volume>92</volume><issue>4</issue><fpage>1491</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1210/jc.2006-1134</pub-id><pub-id pub-id-type="pmid">17213281</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arabi</surname><given-names>A</given-names></name><name><surname>Zahed</surname><given-names>L</given-names></name><name><surname>Mahfoud</surname><given-names>Z</given-names></name><name><surname>El-Onsi</surname><given-names>L</given-names></name><name><surname>Nabulsi</surname><given-names>M</given-names></name><name><surname>Maalouf</surname><given-names>J</given-names></name><name><surname>Fuleihan Gel</surname><given-names>H</given-names></name></person-group><article-title>Vitamin D receptor gene polymorphisms modulate the skeletal response to vitamin D supplementation in healthy girls</article-title><source>Bone</source><year>2009</year><volume>45</volume><issue>6</issue><fpage>1091</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.bone.2009.07.074</pub-id><pub-id pub-id-type="pmid">19647104</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molgaard</surname><given-names>C</given-names></name><name><surname>Larnkjaer</surname><given-names>A</given-names></name><name><surname>Cashman</surname><given-names>KD</given-names></name><name><surname>Lamberg-Allardt</surname><given-names>C</given-names></name><name><surname>Jakobsen</surname><given-names>J</given-names></name><name><surname>Michaelsen</surname><given-names>KF</given-names></name></person-group><article-title>Does vitamin D supplementation of healthy Danish Caucasian girls affect bone turnover and bone mineralization?</article-title><source>Bone</source><year>2010</year><volume>46</volume><issue>2</issue><fpage>432</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.bone.2009.08.056</pub-id><pub-id pub-id-type="pmid">19735754</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wicklow</surname><given-names>BA</given-names></name><name><surname>Taback</surname><given-names>SP</given-names></name></person-group><article-title>Feasibility of a type 1 diabetes primary prevention trial using 2000 IU vitamin D3 in infants from the general population with increased HLA-associated risk</article-title><source>Ann N Y Acad Sci</source><year>2000</year><volume>2006</volume><issue>1079</issue><fpage>310</fpage><lpage>2</lpage></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmlund-Suila</surname><given-names>E</given-names></name><name><surname>Viljakainen</surname><given-names>H</given-names></name><name><surname>Hytinantti</surname><given-names>T</given-names></name><name><surname>Lamberg-Allardt</surname><given-names>C</given-names></name><name><surname>Andersson</surname><given-names>S</given-names></name><name><surname>Makitie</surname><given-names>O</given-names></name></person-group><article-title>High-dose vitamin d intervention in infants--effects on vitamin d status, calcium homeostasis, and bone strength</article-title><source>J Clin Endocrinol Metab</source><year>2012</year><volume>97</volume><issue>11</issue><fpage>4139</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1210/jc.2012-1575</pub-id><pub-id pub-id-type="pmid">22933541</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ireland</surname><given-names>A</given-names></name><name><surname>Ferretti</surname><given-names>JL</given-names></name><name><surname>Rittweger</surname><given-names>J</given-names></name></person-group><article-title>Imaging of the muscle-bone relationship</article-title><source>Curr Osteoporos Rep</source><year>2014</year><volume>12</volume><issue>4</issue><fpage>486</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1007/s11914-014-0216-1</pub-id><pub-id pub-id-type="pmid">25095743</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denny</surname><given-names>FW</given-names></name><name><surname>Collier</surname><given-names>AM</given-names></name><name><surname>Henderson</surname><given-names>FW</given-names></name></person-group><article-title>Acute respiratory infections in day care</article-title><source>Rev Infect Dis</source><year>1986</year><volume>8</volume><issue>4</issue><fpage>527</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1093/clinids/8.4.524</pub-id><pub-id pub-id-type="pmid">3529308</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wald</surname><given-names>ER</given-names></name><name><surname>Guerra</surname><given-names>N</given-names></name><name><surname>Byers</surname><given-names>C</given-names></name></person-group><article-title>Frequency and severity of infections in day care: three-year follow-up</article-title><source>J Pediatr</source><year>1991</year><volume>118</volume><issue>4 Pt 1</issue><fpage>509</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/S0022-3476(05)83370-0</pub-id><pub-id pub-id-type="pmid">2007922</pub-id></element-citation></ref></ref-list></back></article>